Rutledge Matthew R, Waddell J Aubrey, Solimando Dominic A
Mr. Rutledge is Chief, Hematology-Oncology Pharmacy Service, Department of Pharmacy, Madigan Army Medical Center , Tacoma, Washington . The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the US Department of the Army or the Department of Defense.
Hosp Pharm. 2014 Jul;49(7):603-11. doi: 10.1310/hpj4907-603.
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net.
癌症化疗的复杂性要求药剂师熟悉所使用的复杂治疗方案和高毒性药物。本专栏回顾了与抗肿瘤治疗的制备、调配和给药相关的各种问题，以及用于治疗恶性疾病的已上市和正在研究的药物。有关主题的问题或建议应发送至小多米尼克·A·索利曼多（Oncology Pharmacy Services, Inc.总裁，地址：弗吉尼亚州阿灵顿市威尔逊大道4201号#110 - 545，邮编：22203，电子邮箱：OncRxSvc@comcast.net）；或J·奥布里·沃德尔（田纳西大学药学院教授；布朗特纪念医院药剂科肿瘤药师，地址：田纳西州玛丽维尔市东拉马尔·亚历山大大道907号，邮编：37804，电子邮箱：waddfour@charter.net）。
